Investing Should Be Painful
When I tell clients that pain is a strong indicator of good investing, they usually laugh. I admit it sounds like a punch line, but it also happens to be true, and my theory is backed by some strong academic research. Further, I tell clients that, if a … Continue reading at financial-planning.com
Biggest Mistake in Investing in Emerging Markets
32:49 – Bhanu Baweja, head of emerging markets cross asset strategy at UBS, discusses Turkey’s election and the market implications. He speaks to Bloomberg’s Guy Johnson and Anna Edwards on “Countdown.” (Source: Bloomberg) Continue reading at bloomberg.com
Image by technoevangelist
Positive results for positive investing
Positive investing has risen by 11% over the last year according to a report published by Ethex. The amount saved and invested 'positively' across the UK has now reached ?3.6bn, according to the report, with the number of people making positive … Continue reading at thenews.coop
Impact investing must be more than a buzzword
Can impact investing, which aims to provide a tangible social benefit as well as a financial return, move into the mainstream? Large asset managers have placed bets this year that it will: US investment bank Goldman Sachs acquired Imprint Capital, a … Continue reading at ft.com
The difference between investing and gambling
Peter Lynch once said, "When people discover they are no good as baseball or hockey, they put away their bats and their skates and they take up amateur golf or stamp collecting or gardening. But when people discover they are no good at picking stocks … Continue reading at businessinsider.com
Invest in your financial future with this valuable, popular, and easy-to-use guide This latest edition of Investing For Dummies …
Investing is all about common sense. Owning a diversified portfolio of stocks and holding it for the long term is a winner’s game….
The essential stock market guide, now updated with even more timely and necessary informationNow in its fifth edition, The Neatest…
Investing in Pakistan – roadblocks that spring up
Real estate is the most lucrative, risk-averse and popular investment opportunity in Pakistan amongst retail and large investors. Everyone wants to invest small or large savings in real estate instead of starting or expanding a business. What will be the … Continue reading at tribune.com.pk
Keeping an Eye on Robos, But Investing in People
Concern over robo advisors hasn’t touched the segment of wealth management serving the ultra-high-net-worth client. That’s because there isn't much demand for them at that level, says U.S. Trust President Keith Banks. The bigger draw is a firm’s … Continue reading at onwallstreet.com
Image by YoTuT
Comment: 3 tips for investing in your 20s
The wealth of younger Australians isn't keeping up with the rising cost of living. That's according to The Grattan Institute which recently released a report which showed that those in younger age groups have increased their wealth much slower than … Continue reading at sbs.com.au
Matthew McLennan: Crisis Investing
First Eagle Funds' Great Investor Matthew McLennan predicts that we are entering an era of episodic global crises. McLennan is Head of the Global Value Team and Co-Portfolio Manager of several funds at First Eagle, including the flagship First Eagle … Continue reading at valuewalk.com
* Investing made simple: The Motley Fool’s essential guide to investing is now available to the public, free of cost, at http://bit.ly/1atRpHZ. This resource was designed to cover everything that new investors need to know to get started today. For your free copy, just click the link above.
Zogenix (NASDAQ: ZGNX) just took a painful one-two punch on the market today, causing shares to fall 15%. First, the company reported Q4 earnings which missed estimates, but that wasn’t the real story with the company today. Much more painful to the stock was the continued lobbying against the company’s freshly approved painkiller Zohydro. Despite an 11-2 advisory committee vote against approving the drug due to concerns that it had a high potential for abuse, the FDA still decided to approve the extremely effective drug.
In this video, Motley Fool health care analyst David Williamson discusses the vocal opponents of the drug, and highlights the company’s biggest threat: that the FDA would reconsider, and reverse its decision.
Visit us on the web at http://www.fool.com, home to the world’s greatest investing community!
Subscribe to The Motley Fool’s YouTube Channel:
Or, follow our Google+ page:
Inside The Motley Fool: Check out our Culture Blog!
Join our Facebook community:
Follow The Motley Fool on Twitter:
Tweets by themotleyfool
InvestingClick here for reuse options!
Copyright 2015 Stock Market News